Entos, the California-headquartered creator of a platform that utilizes artificial intelligence to design therapies, has secured $53 million in a funding round led by technology investor Coatue to support its breakthrough AI and quantum mechanics-driven drug design efforts.
Other articles
June 28, 2024
Freeflow Ventures Raises $90M In Funding For Early Stage Deep Tech Investments
Freeflow Ventures, announced today that it raised $50M in new funds through its…